Wecome Pharmaceutical Co Ltd (300878) — Cash Flow Quality Index
Wecome Pharmaceutical Co Ltd (300878) has a Cash Flow Quality Index of -0.51x as of September 2024. Operating cash flow of CN¥-15.34 Million is below net income of CN¥29.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Wecome Pharmaceutical Co Ltd cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Wecome Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2022)
Historical Cash Flow Quality Index for Wecome Pharmaceutical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300878 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Wecome Pharmaceutical Co Ltd (2013–2022)
Year-by-year earnings quality comparison for Wecome Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Wecome Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.25x | CN¥146.57 Million | CN¥45.12 Million | ▲ +562.9% |
| 2021 | -0.70x | CN¥-67.74 Million | CN¥96.55 Million | ▼ -322.4% |
| 2020 | 0.32x | CN¥42.81 Million | CN¥135.70 Million | ▼ -64.7% |
| 2019 | 0.89x | CN¥112.76 Million | CN¥126.01 Million | ▼ -25.6% |
| 2018 | 1.20x | CN¥105.57 Million | CN¥87.78 Million | ▲ +294.6% |
| 2017 | 0.30x | CN¥29.00 Million | CN¥95.16 Million | ▼ -75.4% |
| 2016 | 1.24x | CN¥100.15 Million | CN¥80.85 Million | ▲ +109.1% |
| 2015 | 0.59x | CN¥29.63 Million | CN¥50.02 Million | ▼ -75.8% |
| 2014 | 2.45x | CN¥46.01 Million | CN¥18.77 Million | ▲ +35.7% |
| 2013 | 1.81x | CN¥25.98 Million | CN¥14.38 Million | — |